Clinical Trial Update: By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating adoptive transfer of autologous natural killer (NK) cells to prevent recurrence of hepatocellular carcinoma after curative …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• autologous NK cell therapy (autologous natural killer cells)

Snippet

Sponsor: Southwest Hospital, China | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN